Series D Round

Pathos AI is a Boston-based biotech company focused on AI-driven oncology, leveraging advanced artificial intelligence to enhance cancer treatment and research. The company aims to revolutionize the way cancer is diagnosed and treated by utilizing machine learning algorithms to analyze vast datasets, improving patient outcomes and accelerating drug discovery. Pathos AI's innovative platform integrates genomic data, clinical trials, and real-world evidence to provide personalized treatment recommendations for oncologists.